SCHEMBL5815500

SCHEMBL5815500

Nc1nc(-c2cccc(Cl)c2)c(-c2ccnc(NC3CCCCC3)n2)s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 1/20 0.54
ADORA1 P30542 2/20 0.53
MAPK10 P53779 3/20 0.45
MAPK8 P45983 2/20 0.45
MAPK9 P45984 2/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
EIF2AK2 P19525 1/20 0.44
MAPK1 P28482 2/20 0.44
BRAF P15056 1/20 0.43
IKBKB O14920 3/20 0.42
PLK1 P53350 1/20 0.41
CDC7 O00311 1/20 0.41
PLK4 O00444 1/20 0.41
JAK2 O60674 1/20 0.41
CCNB2 O95067 1/20 0.41
MAP4K4 O95819 1/20 0.41
INSR P06213 1/20 0.41
CDK1 P06493 1/20 0.41
CSF1R P07333 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5817779 0.85 ADORA1 (0.52) ADORA1MAPK10MAPK8MAPK9HDAC8
SCHEMBL5819447 0.85 ADORA1 (0.49) ADORA1MAPK10MAPK8MAPK9HDAC8
SCHEMBL5813731 0.85 ADORA1 (0.49) ADORA1MAPK10MAPK8MAPK9HDAC8
SCHEMBL5819449 0.84 ADORA1 (0.52) ADORA1MAPK10MAPK8MAPK9HDAC8
SCHEMBL5823206 0.83 IKBKB (0.52) ADORA1MAPK10MAPK8MAPK9MAPK1
SCHEMBL5815293 0.83 MAPK14 (0.58) TGFBR1ADORA1CDC7PIM1
SCHEMBL3619159 0.83 ADORA1 (0.59) ADORA1MAPK10MAPK8MAPK9HDAC8
SCHEMBL1030530 0.83 ADORA1 (0.59) ADORA1MAPK10MAPK8MAPK9HDAC8
SCHEMBL5823374 0.83 ADORA1 (0.53) ADORA1MAPK10MAPK8MAPK9HDAC8
SCHEMBL5815507 0.82 IKBKB (0.53) ADORA1IKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO disclosed